BioForce Nanosciences Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioForce Nanosciences Holdings generated cash of -$46,702, which is more than the previous year. Cash used in financing activities reached the amount of $46,606 last year. Net change in cash is therefore -$96.
Cash Flow
| 2014 | 0 | 0 | 0 |
|---|---|---|---|
| 2015 | 0 | 0 | 7 |
| 2016 | -3.21K | 0 | 6.5K |
| 2017 | -25.89K | 0 | 25.89K |
| 2018 | -62.46K | 0 | 77.53K |
| 2019 | -24.38K | 0 | 47.88K |
| 2020 | -80.19K | 0 | 67.16K |
| 2021 | -77.77K | 0 | 49.01K |
| 2022 | -68.38K | 0 | 58.01K |
| 2023 | -46.70K | 0 | 46.60K |
BFNH Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 734 | 11.10K | 39.86K | 52.89K | 29.39K | 14.32K | 14.32K | 17.16K | 19.11K | 22.16K |
Operating activities | ||||||||||
Net income | -471.95K | -485.51K | -501.95K | -158.40M | -46.53K | -67.73K | -31.26K | -5.71K | -2.5K | -2.5K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 158M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 158M | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 5.73K | -1.23K | -4.5K | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.25K | -5.91K | 1.22K | -5.15K | 4.92K | 3.42K | 9.86K | 7.79K | 0 | 0 |
Cash generated by operating activities | -46.70K | -68.38K | -77.77K | -80.19K | -24.38K | -62.46K | -25.89K | -3.21K | 0 | 0 |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 100 | 0 | 0 | 47.88K | 77.53K | 25.89K | 6.5K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 46.60K | 58.01K | 49.01K | 67.16K | 47.88K | 77.53K | 25.89K | 6.5K | 7 | 0 |
Net Change In Cash | -96 | -10.37K | -28.76K | -13.03K | 23.50K | 15.06K | 0 | -2.5K | -1.95K | -2.25K |
Cash at end of period | 638 | 734 | 11.10K | 39.86K | 52.89K | 29.39K | 14.32K | 14.66K | 17.16K | 19.91K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |